SPOTLIGHT: Boehringer launch aided by charity

Boehringer Ingelheim launched its blood thinner Pradaxa last week, getting a media boost from the backing of Lifeblood, a charity that's been lobbying for changes to the National Institute for Clinical Excellence's thrombosis treatment guidelines. Release | Report